In the BioHarmony Drug Report Database

"Preview" Icon

Elosulfase alfa

Vimizim (elosulfase alfa) is an enzyme pharmaceutical. Elosulfase alfa was first approved as Vimizim on 2014-02-14. It is used to treat mucopolysaccharidosis IV in the USA. It has been approved in Europe to treat mucopolysaccharidosis IV.

 

Trade Name

 

Vimizim
 

Common Name

 

elosulfase alfa
 

ChEMBL ID

 

CHEMBL2108676
 

Indication

 

mucopolysaccharidosis iv
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Elosulfase alfa structure rendering